Comprehensive Connected Cancer Care (C4): Intervention Evaluation
The C4 program aims to provide a multi-level intervention program (Patient Level, Healthcare Team and Healthcare System Level) that improves the coordination of care with supportive/ancillary care providers and community services through the use of patient navigation and a digital needs assessment and a closed-loop ref
| Condition(s) | Cancer, Health Care Utilization |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The C4 program aims to provide a multi-level intervention program (Patient Level, Healthcare Team and Healthcare System Level) that improves the coordination of care with supportive/ancillary care providers and community services through the use of patient navigation and a digital needs assessment and a closed-loop referral system and improves patient-centered communication and engagement in care through skills training for the healthcare team and provision of culturally appropriate patient educational tools and resources. The program components incorporate three areas that are critical to improving patient-centered care: coordination of care, patient-centered communication and engagement, and psychosocial care and other supportive services. |
| Who can participate | Inclusion Criteria: * Patients with newly diagnosed or recurrent cancer who have not initiated treatment of any kind, including surgery, medical management, and/or radiation * Patients with one reported social determinants of health (SDOH) need OR patients at high-risk for SDOH needs based on demographic information (racial \& ethnic minorities, medicaid/uninsured populations). * Willingness to provide informed consent to participate Exclusion Criteria: * Not able to understand and communicate in English * Unable and/or unwilling to access the internet on a phone, tablet, or computer |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Timothy Mullett |
| Locations | Lexington, Kentucky, United States |
| Start date | 2024-02-01 |
| NCT ID | NCT06326567 |
| Official listing | https://clinicaltrials.gov/study/NCT06326567 |